HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Yibin Liu Selected Research
Yibin Liu Research Topics
Disease
20
Neoplasms (Cancer)
01/2024 - 01/2016
4
Hypoxia (Hypoxemia)
01/2022 - 01/2018
3
Adenocarcinoma
08/2022 - 05/2019
2
Glioblastoma (Glioblastoma Multiforme)
01/2023 - 01/2023
2
Obstructive Sleep Apnea
01/2022 - 01/2021
2
Hepatocellular Carcinoma (Hepatoma)
09/2021 - 01/2021
2
Osteoarthritis
01/2021 - 01/2019
2
Coronary Artery Disease (Coronary Atherosclerosis)
01/2019 - 01/2018
2
Neoplasm Metastasis (Metastasis)
10/2018 - 03/2017
1
Diabetic Foot
04/2024
1
Wounds and Injuries (Trauma)
04/2024
1
Diabetes Mellitus
04/2024
1
Foot Ulcer
04/2024
1
Ulcer
04/2024
1
Dehydration (Water Stress)
12/2023
1
Nasopharyngeal Carcinoma
11/2023
1
Nausea
07/2023
1
Postoperative Nausea and Vomiting (PONV)
07/2023
1
Vomiting
07/2023
1
Glioma (Gliomas)
01/2023
1
Mitochondrial Diseases (Mitochondrial Disease)
01/2023
1
Ovarian Neoplasms (Ovarian Cancer)
01/2023
1
Drug Eruptions (Drug Eruption)
11/2022
1
Invasive Hydatidiform Mole (Invasive Mole)
11/2022
1
Erythema
11/2022
1
Erythema Multiforme
11/2022
1
Left Ventricular Dysfunction
10/2022
1
Ventricular Remodeling
10/2022
1
Hemorrhage
04/2022
1
COVID-19
02/2022
1
Allergic Rhinitis
02/2022
1
Encephalitis (Encephalitis, Rasmussen)
01/2022
1
Autoimmune Diseases of the Nervous System
01/2022
1
Teratoma (Teratoid Tumor)
01/2022
1
Ovarian Teratoma
01/2022
1
Anti-N-Methyl-D-Aspartate Receptor Encephalitis
01/2022
1
Fetal Hypoxia
11/2021
1
Myocardial Ischemia (Ischemic Heart Diseases)
11/2021
1
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2021
Drug/Important Bio-Agent (IBA)
5
Proteins (Proteins, Gene)
FDA Link
08/2022 - 01/2018
4
DNA (Deoxyribonucleic Acid)
IBA
01/2023 - 11/2016
3
Cell-Free Nucleic Acids
IBA
09/2021 - 11/2016
2
Paclitaxel (Taxol)
FDA Link
Generic
01/2023 - 01/2016
2
1-phenyl-3,3-dimethyltriazene (PDT)
IBA
01/2023 - 09/2022
2
Reactive Oxygen Species (Oxygen Radicals)
IBA
01/2023 - 05/2019
2
MicroRNAs (MicroRNA)
IBA
01/2022 - 05/2019
2
safranine T (safranin)
IBA
01/2021 - 01/2019
2
Chimeric Antigen Receptors
IBA
01/2021 - 05/2019
2
Enzymes
IBA
12/2020 - 01/2017
2
Sirolimus (Rapamycin)
FDA Link
10/2020 - 01/2019
2
Biomarkers (Surrogate Marker)
IBA
10/2018 - 01/2017
1
Carcinoembryonic Antigen
IBA
01/2024
1
Tumor Biomarkers (Tumor Markers)
IBA
01/2024
1
Silica Gel
IBA
12/2023
1
Capsules (Microcapsules)
IBA
12/2023
1
Analgesics (Analgesic Drugs)
IBA
07/2023
1
Ondansetron (Zofran)
FDA Link
Generic
07/2023
1
Dexamethasone (Maxidex)
FDA Link
Generic
07/2023
1
Aprepitant (Emend)
FDA Link
07/2023
1
SOXC Transcription Factors
IBA
01/2023
1
T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)
IBA
01/2023
1
Antigens
IBA
01/2023
1
RNA (Ribonucleic Acid)
IBA
01/2023
1
5-Methylcytosine (5 Methylcytosine)
IBA
01/2023
1
Micelles
IBA
01/2023
1
Dactinomycin (Actinomycin)
FDA Link
Generic
11/2022
1
Fluorouracil (Carac)
FDA Link
Generic
11/2022
1
omega-Chloroacetophenone (Mace)
IBA
10/2022
1
Photosensitizing Agents (Photosensitizers)
IBA
04/2022
1
Tubulin
IBA
04/2022
1
N-Methyl-D-Aspartate Receptors (NMDA Receptors)
IBA
01/2022
1
N-Methylaspartate (NMDA)
IBA
01/2022
1
AQ4N
IBA
01/2022
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2022
1
Intravenous Immunoglobulins (IVIG)
FDA Link
01/2022
1
Circular RNA
IBA
01/2022
1
Steroids
IBA
01/2022
1
Antibodies
IBA
01/2022
1
Carbonic Anhydrase III
IBA
11/2021
1
Oxygen (Dioxygen)
IBA
11/2021
1
Messenger RNA (mRNA)
IBA
11/2021
1
Metals
IBA
10/2021
1
Doxorubicin (Adriamycin)
FDA Link
Generic
10/2021
1
morusin
IBA
10/2021
1
artenimol (dihydroartemisinin)
IBA
01/2021
1
ibrutinib
IBA
01/2021
1
Glucose (Dextrose)
FDA Link
Generic
12/2020
Therapy/Procedure
8
Therapeutics
09/2022 - 03/2017
5
Immunotherapy
01/2023 - 05/2019
3
Photochemotherapy (Photodynamic Therapy)
01/2023 - 04/2022
2
Drug Therapy (Chemotherapy)
11/2022 - 04/2022
2
Intravenous Administration
04/2022 - 01/2022
1
Negative-Pressure Wound Therapy
04/2024
1
Surgical Amputation (Amputations)
04/2024
1
Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
11/2023
1
Analgesia
07/2023
1
Treatment Delay
02/2022
1
Plasma Exchange
01/2022
1
Continuous Positive Airway Pressure
01/2021
1
Radiofrequency Ablation
01/2021